WQ
REGN icon

Wealth Quarterback’s Regeneron Pharmaceuticals REGN Stock Holding History

Wealth Quarterback’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$116K Buy
4,427
+4,228
+2,125% +$2.62M 0.08% 148
2021
Q2 		$112K Buy
+199
New +$101K 0.07% 162
2020
Q4 		– Sell
-367
Closed -$229K – 122
2020
Q3 		$229K Hold
367
– – 0.21% 101
2020
Q2 		$229K Sell
367
-80
-18% -$45.4K 0.21% 101
2020
Q1 		$194K Sell
447
-149
-25% -$61.5K 0.18% 104
2019
Q4 		$224K Buy
+596
New +$201K 0.19% 101

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Wealth Quarterback's REGN Position: Q3 2021 in Review

Wealth Quarterback increased its Regeneron Pharmaceuticals (REGN) stake by 2,125% in Q3 2021, buying an estimated $2.62M and bringing the position to 4,427 shares worth $116K. The position accounts for 0.08% of the portfolio, ranked #148.

Wealth Quarterback first reported a position in REGN in Q4 2019 and has held it in 6 quarters since. The position peaked at $229K in Q3 2020. 1,019 funds tracked by Wall St. Rank hold REGN as of Q3 2021.

  • Wealth Quarterback held 4,427 shares of Regeneron Pharmaceuticals worth $116K as of Q3 2021.
  • Wealth Quarterback bought 4,228 Regeneron Pharmaceuticals shares in Q3 2021, an estimated $2.62M.
  • Regeneron Pharmaceuticals made up 0.08% of Wealth Quarterback's portfolio in Q3 2021, its #148 holding.
  • Wealth Quarterback first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 6 quarters since.
  • Wealth Quarterback's Regeneron Pharmaceuticals position peaked at $229K in Q3 2020.
  • 1,019 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2021.

Based on Wealth Quarterback's 13F filing for Q3 2021, filed 17 Nov 2021.